Key result
ISAR score outperforms benchmark models in predicting 1-year repeat PCI for recurrent DES-ISR.
Why the study?
Treatment of drug-eluting stent in-stent restenosis is challenging due to a high risk of recurrence, prompting the need for a model to predict the risk of repeat PCI for recurrent restenosis.
Does the ISAR score accurately predict the risk of repeat PCI for recurrent DES-ISR at 1 year compared to a benchmark ISR classification model?
Observational (n=1,986)
Yes
Does the ISAR score accurately predict the risk of repeat PCI for recurrent DES-ISR at 1 year compared to a benchmark ISR classification model?
The ISAR score is a novel, validated tool that predicts the 1-year risk of repeat PCI for recurrent DES-ISR better than benchmark classification models.
Answers are grounded in this paper and cite their sources.
Modest gain in predicting recurrent DES-ISR should not yet change practice; leaves open need for prospective validation.
BACKGROUND: The treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is challenging as it has a high risk of recurrence. AIMS: The aim of this analysis was to develop and validate a model to predict the risk of repeat percutaneous coronary intervention (PCI) for recurrent DES-ISR. METHODS: A retrospective, observational analysis was performed including consecutive patients treated with PCI for DES-ISR at two centres in Germany. Included patients were randomly divided into training and validation cohorts. Two regression analyses identified factors associated with repeat PCI for recurrent DES-ISR up to 1 year. The discriminative ability of the resultant model was then compared to a benchmark ISR classification model using bootstrap resampling. A classification and regression tree analysis and a numerical scoring system (the ISAR score) were used to predict the risk of repeat PCI for recurrent DES-ISR based on the identified predictors. RESULTS: We included 1,986 patients in the current analysis, divided randomly into training (1,471 patients, 1,778 lesions) and validation (515 patients, 614 lesions) cohorts. Four factor variables (a non-focal ISR pattern, a time interval to ISR of <6 months, ISR of the left circumflex artery and ISR in a calcified vessel) were associated with repeat PCI for recurrent DES-ISR at 1-year follow-up. On bootstrap resampling analysis, the C-statistic for the model including these four variables was 0.60 (95% confidence interval [CI]: 0.57-0.63), whereas the C-statistic for the benchmark ISR classification model was 0.54 (95% CI: 0.52-0.57), a difference that was statistically significant (delta C-statistic 0.062; 95% CI: 0.035-0.094; p<0.001). The cumulative incidence of repeat PCI for recurrent DES-ISR was over three times higher in DES-ISR lesions with an ISAR score of ≥3 in comparison to lesions with an ISAR score of 0. CONCLUSIONS: This study developed and validated a risk prediction model for repeat PCI for recurrent DES-ISR at 1-year follow-up. This model served to generate the ISAR score, a standardised tool that can be used to predict the 1-year risk of repeat PCI for recurrent DES-ISR.
No takes yet. Share an insight, caveat, or question.
Coughlan et al. (2023) conducted an observational in drug-eluting stent (DES) in-stent restenosis (ISR) (n=1,986). ISAR score vs. benchmark ISR classification model was evaluated on repeat PCI for recurrent DES-ISR at 1-year follow-up (delta C-statistic 0.062, 95% CI 0.035-0.094, p=<0.001). The ISAR score predicted repeat PCI for recurrent DES-ISR at 1 year with a C-statistic of 0.60, outperforming the benchmark model.
Synapse has enriched 10 related papers. Consider them for comparative context: